CHORUS ADENOVIRUS IGG
Mexico·Clase I·III. DIAGNOSTIC AGENTS·GRIFOLS MÉXICO, S.A. DE C.V.·Registered April 24, 2019REACTIVO PARA LA DETERMINACIÓN CUALITATIVA DE ANTICUERPOS IGG ANTI-ADENOVIRUS
REAGENT FOR THE QUALITATIVE DETERMINATION OF ANTI-ADENOVIRUS IGG ANTIBODIES
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVO PARA LA DETERMINACIÓN CUALITATIVA DE ANTICUERPOS IGG ANTI-ADENOVIRUS
- Trade Name (English)
- REAGENT FOR THE QUALITATIVE DETERMINATION OF ANTI-ADENOVIRUS IGG ANTIBODIES
- Analysis ID
- 845R2019 SSA
- Registration Date
- April 24, 2019
- Name (Spanish)
- GRIFOLS MÉXICO, S.A. DE C.V.
- Name (English)
- GRIFOLS MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for CHORUS ADENOVIRUS IGG (CHORUS ADENOVIRUS IGG) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 845R2019 SSA and manufactured by GRIFOLS MÉXICO, S.A. DE C.V.. The device was registered on April 24, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.